The TWEAK/Fn14 axis was first described ~12 years ago, and since that time studies from around the globe have revealed that Fn14-triggered signal transduction and downstream cellular responses could potentially play a role in the pathophysiology of many major human diseases, including cardiovascular disease, stroke, and cancer. The gene discussed is TNFRSF12A; the disease is stroke disorder.